Gamma-Hydroxybutyrate content in dried bloodspots facilitates newborn detection of succinic semialdehyde dehydrogenase deficiency

Madalyn Brown, Paula Ashcraft, Erland Arning, Teodoro Bottiglieri, Jean-Baptiste Roullet, K. Michael Gibson

Research output: Contribution to journalArticle

Abstract

Increased gamma-hydroxybutyric acid in urine and blood are metabolic hallmarks of succinic semialdehyde dehydrogenase deficiency, a defect of 4-aminobutyric acid metabolism. Here, we examined the hypothesis that succinic semialdehyde dehydrogenase deficiency could be identified via measurement of gamma-hydroxybutyric acid in newborn and post-newborn dried bloodspots. Quantitation of gamma-hydroxybutyric acid using liquid chromatography-tandem mass spectrometry in twelve archival newborn patient dried bloodspots was 360 ± 57 μM (mean, standard error; range 111–767), all values exceeding the previously established cutoff for newborn detection of 78 μΜ established from 2831 dried bloodspots derived from newborns, neonates and children. Gamma-hydroxybutyric acid in post-newborn dried bloodspots (n = 19; ages 0.8–38 years) was 191 ± 65 μM (mean, standard error; range 20–1218), exceeding the aforementioned GHB cutoff for patients approximately 10 years of age or younger. Further, gamma-hydroxybutyric acid in post-newborn dried bloodspots displayed a significant (p <.0001) inverse correlation with age. This preliminary study suggests that succinic semialdehyde dehydrogenase deficiency may be identified in newborn and post-newborn dried bloodspots via quantitation of gamma-hydroxybutyric acid, while forming the platform for more extensive studies in affected and unaffected dried bloodspots.

Original languageEnglish (US)
JournalMolecular Genetics and Metabolism
DOIs
StatePublished - Jan 1 2019

Fingerprint

Succinate-Semialdehyde Dehydrogenase
Sodium Oxybate
Newborn Infant
Liquid chromatography
Metabolism
gamma-Aminobutyric Acid
Mass spectrometry
4-hydroxybutyric acid
succinic semialdehyde dehydrogenase deficiency
Blood
Defects
Tandem Mass Spectrometry
Liquid Chromatography

Keywords

  • Dried bloodspots
  • GABA metabolism
  • Gamma-hydroxybutyric acid
  • Newborn screening

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Cite this

Gamma-Hydroxybutyrate content in dried bloodspots facilitates newborn detection of succinic semialdehyde dehydrogenase deficiency. / Brown, Madalyn; Ashcraft, Paula; Arning, Erland; Bottiglieri, Teodoro; Roullet, Jean-Baptiste; Gibson, K. Michael.

In: Molecular Genetics and Metabolism, 01.01.2019.

Research output: Contribution to journalArticle

Brown, Madalyn ; Ashcraft, Paula ; Arning, Erland ; Bottiglieri, Teodoro ; Roullet, Jean-Baptiste ; Gibson, K. Michael. / Gamma-Hydroxybutyrate content in dried bloodspots facilitates newborn detection of succinic semialdehyde dehydrogenase deficiency. In: Molecular Genetics and Metabolism. 2019.
@article{5114f44d4bcf4429880b94e2b6eef913,
title = "Gamma-Hydroxybutyrate content in dried bloodspots facilitates newborn detection of succinic semialdehyde dehydrogenase deficiency",
abstract = "Increased gamma-hydroxybutyric acid in urine and blood are metabolic hallmarks of succinic semialdehyde dehydrogenase deficiency, a defect of 4-aminobutyric acid metabolism. Here, we examined the hypothesis that succinic semialdehyde dehydrogenase deficiency could be identified via measurement of gamma-hydroxybutyric acid in newborn and post-newborn dried bloodspots. Quantitation of gamma-hydroxybutyric acid using liquid chromatography-tandem mass spectrometry in twelve archival newborn patient dried bloodspots was 360 ± 57 μM (mean, standard error; range 111–767), all values exceeding the previously established cutoff for newborn detection of 78 μΜ established from 2831 dried bloodspots derived from newborns, neonates and children. Gamma-hydroxybutyric acid in post-newborn dried bloodspots (n = 19; ages 0.8–38 years) was 191 ± 65 μM (mean, standard error; range 20–1218), exceeding the aforementioned GHB cutoff for patients approximately 10 years of age or younger. Further, gamma-hydroxybutyric acid in post-newborn dried bloodspots displayed a significant (p <.0001) inverse correlation with age. This preliminary study suggests that succinic semialdehyde dehydrogenase deficiency may be identified in newborn and post-newborn dried bloodspots via quantitation of gamma-hydroxybutyric acid, while forming the platform for more extensive studies in affected and unaffected dried bloodspots.",
keywords = "Dried bloodspots, GABA metabolism, Gamma-hydroxybutyric acid, Newborn screening",
author = "Madalyn Brown and Paula Ashcraft and Erland Arning and Teodoro Bottiglieri and Jean-Baptiste Roullet and Gibson, {K. Michael}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ymgme.2019.07.010",
language = "English (US)",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Gamma-Hydroxybutyrate content in dried bloodspots facilitates newborn detection of succinic semialdehyde dehydrogenase deficiency

AU - Brown, Madalyn

AU - Ashcraft, Paula

AU - Arning, Erland

AU - Bottiglieri, Teodoro

AU - Roullet, Jean-Baptiste

AU - Gibson, K. Michael

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Increased gamma-hydroxybutyric acid in urine and blood are metabolic hallmarks of succinic semialdehyde dehydrogenase deficiency, a defect of 4-aminobutyric acid metabolism. Here, we examined the hypothesis that succinic semialdehyde dehydrogenase deficiency could be identified via measurement of gamma-hydroxybutyric acid in newborn and post-newborn dried bloodspots. Quantitation of gamma-hydroxybutyric acid using liquid chromatography-tandem mass spectrometry in twelve archival newborn patient dried bloodspots was 360 ± 57 μM (mean, standard error; range 111–767), all values exceeding the previously established cutoff for newborn detection of 78 μΜ established from 2831 dried bloodspots derived from newborns, neonates and children. Gamma-hydroxybutyric acid in post-newborn dried bloodspots (n = 19; ages 0.8–38 years) was 191 ± 65 μM (mean, standard error; range 20–1218), exceeding the aforementioned GHB cutoff for patients approximately 10 years of age or younger. Further, gamma-hydroxybutyric acid in post-newborn dried bloodspots displayed a significant (p <.0001) inverse correlation with age. This preliminary study suggests that succinic semialdehyde dehydrogenase deficiency may be identified in newborn and post-newborn dried bloodspots via quantitation of gamma-hydroxybutyric acid, while forming the platform for more extensive studies in affected and unaffected dried bloodspots.

AB - Increased gamma-hydroxybutyric acid in urine and blood are metabolic hallmarks of succinic semialdehyde dehydrogenase deficiency, a defect of 4-aminobutyric acid metabolism. Here, we examined the hypothesis that succinic semialdehyde dehydrogenase deficiency could be identified via measurement of gamma-hydroxybutyric acid in newborn and post-newborn dried bloodspots. Quantitation of gamma-hydroxybutyric acid using liquid chromatography-tandem mass spectrometry in twelve archival newborn patient dried bloodspots was 360 ± 57 μM (mean, standard error; range 111–767), all values exceeding the previously established cutoff for newborn detection of 78 μΜ established from 2831 dried bloodspots derived from newborns, neonates and children. Gamma-hydroxybutyric acid in post-newborn dried bloodspots (n = 19; ages 0.8–38 years) was 191 ± 65 μM (mean, standard error; range 20–1218), exceeding the aforementioned GHB cutoff for patients approximately 10 years of age or younger. Further, gamma-hydroxybutyric acid in post-newborn dried bloodspots displayed a significant (p <.0001) inverse correlation with age. This preliminary study suggests that succinic semialdehyde dehydrogenase deficiency may be identified in newborn and post-newborn dried bloodspots via quantitation of gamma-hydroxybutyric acid, while forming the platform for more extensive studies in affected and unaffected dried bloodspots.

KW - Dried bloodspots

KW - GABA metabolism

KW - Gamma-hydroxybutyric acid

KW - Newborn screening

UR - http://www.scopus.com/inward/record.url?scp=85069739908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069739908&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2019.07.010

DO - 10.1016/j.ymgme.2019.07.010

M3 - Article

AN - SCOPUS:85069739908

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

ER -